Recent studies have already shown that kinase inhibition can alleviate mitochondrial dysfunction in mouse models of mitochondrial disease by dampening mTOR, PKC, or AMPK signaling (51, 52, 53). This evidence concerns the gene PRRT2 and mitochondrial disease.